Summary

India Veterinary Medicine Market Summary

The India veterinary medicine market size was estimated at USD 1.73 billion in 2024 and is projected to reach USD 4.17 billion by 2033, growing at a CAGR of 10.23% from 2025 to 2033. The market is experiencing growth due to rising awareness about the importance of animal healthcare, a growing number of animal disease outbreaks, and increasing demand for animal-derived protein. Additionally, new product launches, advancements in veterinary medicine, and strong regulatory support contribute to this growth. Government initiatives in India, such as the National Programme for Dairy Development, the Rashtriya Gokul Mission, and the Animal Husbandry Infrastructure Development Fund, are also key in driving market expansion.

Moreover, in 2024, India ramped up efforts to increase milk production through strategic public-private partnerships, which have notably influenced the country’s veterinary medicine market. In collaboration with private stakeholders, the government introduced several initiatives to strengthen dairy infrastructure and boost productivity. For example, as reported by EGNIOL in February 2024, one key initiative is the Animal Husbandry Infrastructure Development Fund (AHIDF)-a ₹15,000 crore (USD 1,718.07 million) fund designed to attract private sector investment in areas such as dairy plants, meat processing units, and animal feed facilities. This program aims to support Farmer Producer Organizations (FPOs), Micro, Small, and Medium Enterprises (MSMEs), and individual entrepreneurs engaged in the animal husbandry sector.

Similarly, the Indian government has been actively promoting the development of the veterinary medicine market through various initiatives. One of these initiatives includes establishing the National Animal Disease Control Program (NADCP), which aims to control and eradicate major animal diseases in the country. Additionally, the government has launched several schemes to encourage the use of modern veterinary practices and technologies, driving market growth. For instance, in June 2023, the Indian government launched the Nandi portal, a tool developed by the Central Drugs Standard Control Organization and in collaboration with the Department of Animal Husbandry and Dairying (DAHD) to streamline the regulatory approval process for veterinary products, aiming to enhance transparency and efficiency in assessing and examining proposals for veterinary drugs and vaccines.

India’s vast livestock population of over 536 million, the largest globally, combined with the heavy dependence of nearly 70% of rural households on animals for livelihood, food security, and income, creates a strong foundation for sustained demand in the veterinary medicine market. Government initiatives such as the National Animal Disease Control Programme (NADCP) significantly amplify this demand. As reported by the Ministry of Fisheries, Animal Husbandry & Dairying in April 2025, massive vaccine deployment-114.56 crore FMD doses and 4.57 crore Brucellosis doses reflects the scale of national efforts to curb endemic diseases. The NADCP’s dual goals of controlling Foot and Mouth Disease (FMD) by 2025 and eradicating it 2030 through regular immunization directly stimulate demand for vaccines, diagnostics, and therapeutic veterinary products. These large-scale disease eradication programs increase public and private investments, improve supply chain infrastructure, and create long-term opportunities for pharmaceutical companies and service providers. Consequently, the emphasis on preventive healthcare and mass vaccination is a key driver accelerating growth in India's veterinary medicine market.

India Veterinary Medicine Market Report Segmentation

This report forecasts revenue growth provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the India veterinary medicine market report based on product, animal type, route of administration, and distribution channel:
• Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
• Production Animals
o Poultry
o Pigs
o Cattle
o Sheep & Goats
o Others
• Companion Animals
o Dogs
o Cats
o Horses
o Others
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Biologics
o Vaccines
o Modified/ Attenuated Live
o Inactivated (Killed)
o Other Vaccines
o Other Biologics
• Pharmaceuticals
o Parasiticides
o Anti-infectives
o Anti-inflammatory
o Analgesics
o Others
• Medicated Feed Additives
• Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
• Oral
• Injectable
• Topical
• Others
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Hospitals & Clinics
• E-commerce
• Offline Retail Stores
• Others

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. GVR’s Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.3.6. Data analysis model
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Volume price analysis
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. India Veterinary Medicine Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising demand for animal derived products
3.2.1.2. Shift toward antibiotic alternatives
3.2.1.3. Technological advancements in veterinary medicines
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory compliance and approval processes
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. India Veterinary Medicine Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Legal landscape
3.3.2.3. Economic landscape
3.3.2.4. Social landscape
3.3.2.5. Technological landscape
3.3.2.6. Environmental landscape
3.3.3. Regulatory Framework
3.3.4. Pricing Analysis
3.3.5. Product Pipeline Analysis
3.3.6. Estimated Animal Population in India, 2024
Chapter 4. India Veterinary Medicine Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. India Veterinary Medicine Market: Animal Type, Market Share 2024 & 2033
4.3. India Veterinary Medicine Market Size & Trend Analysis, by Animal Type, 2021 to 2033 (USD Million)
4.4. Production
4.4.1. Production Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. Poultry
4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. Cattle
4.4.3.1. Cattle Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.4. Pigs
4.4.4.1. Pigs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.5. Sheep & Goat
4.4.5.1. Sheep & Goat Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.6. Others
4.4.6.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5. Companion
4.5.1. Companion Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.2. Dogs
4.5.2.1. Dogs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.3. Cats
4.5.3.1. Cats Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.4. Horses
4.5.4.1. Horses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
4.5.5. Others
4.5.5.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. India Veterinary Medicine Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. India Veterinary Medicine Market: Product, Market Share 2024 & 2033
5.3. India Veterinary Medicine Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
5.4. Biologics
5.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.1. Vaccines
5.4.1.1.1. Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.2. Modified/ Attenuated Live
5.4.1.2.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.3. Inactivated (Killed)
5.4.1.3.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.1.4. Other Vaccines
5.4.1.4.1. Other Vaccines Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4.2. Other Biologics
5.4.2.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Pharmaceuticals
5.5.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.1. Parasiticides
5.5.1.1.1. Parasiticides Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.2. Anti-infectives
5.5.1.2.1. Anti-infectives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.3. Analgesics
5.5.1.3.1. Analgesics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5.1.4. Others
5.5.1.4.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Medicated Feed Additives
5.6.1. Medicated Feed Additives Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. India Veterinary Medicine Market: By Route of Administration Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. India Veterinary Medicine Market: By Route of Administration, Market Share 2024 & 2033
6.3. India Veterinary Medicine Market Size & Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
6.3.1. Oral
6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.2. Injectable
6.3.2.1. Injectable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.3. Topical
6.3.3.1. Topical Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.3.4. Others
6.3.4.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. India Veterinary Medicine Market: By Distribution Channel Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. India Veterinary Medicine Market: By Distribution Channel, Market Share 2024 & 2033
7.3. India Veterinary Medicine Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
7.3.1. Veterinary Hospitals & Clinics
7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.2. E-commerce
7.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.3. Offline Retail Stores
7.3.3.1. Offline Retail Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
7.3.4. Others
7.3.4.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Market Participant Categorization
8.2. Company Market Position Analysis/ Heat Map Analysis
8.3. Company Profiles
8.3.1. Boehringer Ingelheim International GmbH.
8.3.1.1. Participant’s Overview
8.3.1.2. Financial Performance
8.3.1.3. Product Benchmarking
8.3.1.4. Strategic Initiatives
8.3.2. Zoetis
8.3.2.1. Participant’s Overview
8.3.2.2. Financial Performance
8.3.2.3. Product Benchmarking
8.3.2.4. Strategic Initiatives
8.3.3. IDEXX Laboratories, Inc.
8.3.3.1. Participant’s Overview
8.3.3.2. Financial Performance
8.3.3.3. Product Benchmarking
8.3.3.4. Strategic Initiatives
8.3.4. Merck & Co., Inc.
8.3.4.1. Participant’s Overview
8.3.4.2. Financial Performance
8.3.4.3. Product Benchmarking
8.3.4.4. Strategic Initiatives
8.3.5. Ceva Santé Animale
8.3.5.1. Participant’s Overview
8.3.5.2. Financial Performance
8.3.5.3. Product Benchmarking
8.3.5.4. Strategic Initiatives
8.3.6. Elanco
8.3.6.1. Participant’s Overview
8.3.6.2. Financial Performance
8.3.6.3. Product Benchmarking
8.3.6.4. Strategic Initiatives
8.3.7. Hester Biosciences Limited
8.3.7.1. Participant’s Overview
8.3.7.2. Financial Performance
8.3.7.3. Product Benchmarking
8.3.7.4. Strategic Initiatives
8.3.8. Virbac
8.3.8.1. Participant’s Overview
8.3.8.2. Financial Performance
8.3.8.3. Product Benchmarking
8.3.8.4. Strategic Initiatives
8.3.9. Phibro Animal Health Corporation
8.3.9.1. Participant’s Overview
8.3.9.2. Financial Performance
8.3.9.3. Product Benchmarking
8.3.9.4. Strategic Initiatives
8.3.10. Dechra Pharmaceuticals Plc
8.3.10.1. Participant’s Overview
8.3.10.2. Financial Performance
8.3.10.3. Product Benchmarking
8.3.10.4. Strategic Initiatives
8.4. Strategy Mapping
8.4.1. Mergers & Acquisitions
8.4.2. Partnerships & Collaborations
8.4.3. Product launch
8.4.4. Others
8.5. List of other key players